JPRN-UMIN000003831已完成1 期
A phase 1 study of a combination chemotherapy, Sorafenib and intrahepatic arterial infusion of IA-call® (DDP-H), for advanced hepatocellular carcinoma. - A combination chemotherapy of Sorafenib and DDP-H for HCC (Phase 1).
iigata Hepatocellular Carcinoma Therapy Study Group0 个研究点目标入组 15 人开始时间: 2010年7月1日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 79years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Pleural effusion and/or ascites refractory to treatments. 2)Comorbidity: a)Hyper tension over 100mmHg of diastolic blood pressure under medication. b)Uncontrollable heart failure, angina pectoris or arrhythmia. c)Myocardial infarction within 6 months. d)Brain metastasis. e)Active infectious diseases except for hepatitis. f)Active bleeding from GI tract. g)Active concomitant cancer with invasive nature. h)Severe mental disorder or hepatic encephalopathy. 3)A history of severe allergic reaction against iodine contrast medium and/or platinum agents. 4)A pregnant or lactating female or female of childbearing age unless using effective contraception. 5)Ongoing interferon therapy. 6)Difficulties of oral intake. 7)Other serious conditions judged to be inadequate by a responsible doctor.
研究者
相似试验
已完成
1 期
A phase I study of the combination chemotherapy of IRISOX (irinotecan/S-1/oxaliplatin) in gemcitabine-refractory pancreatic cancergemcitabine-refractory pancreatic cancerJPRN-UMIN000022964Kitasato University School of Medicine12
已完成
不适用
A Phase I/II Trial of Combined Chemotherapy with S-1 and Irinotecan in Patients with Recurrent Cervical Cancer.Recurrent Cervical CancerJPRN-UMIN000016302Dept of Obstetrics and Gynecology, Osaka University Hospital.30
已完成
1 期
Phase I-II study of combination chemotherapy with Irinotecan and Gemcitabine for clear cell or mucinous ovarian cancerClear cell or mucinous ovarian cancerJPRN-UMIN000005952Osaka university, faculty of medicine40
已完成
1 期
Phase I/II study of combination chemotherapy with Paclitaxel and TS-1 and Cisplatin for unresectable/ recurrent gastric cancerunresectable or recurrent gastric cancerJPRN-UMIN000004729School of Medicine, Keio University40
招募中
2 期
Phase II study of combination chemotherapy with S-1 plus Avastin in unresectable or recurrent colorectal cancer after failure of prior chemotherapy, including irinotecan and oxaliplatin regimens.colorectal cancerJPRN-UMIN000002308Translational Research Informatics Center(TRI)40